IDiyas

For the Inventor, By the Inventor

Rome, Italy

Giorgio Tarzia

USPTO Granted Patents = 19

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • Rome, IT (1976 - 1980)
  • Milan, IT (1983 - 1988)
  • Vicolo San Clemente, IT (1993)
  • Saronno, IT (1988 - 1996)

Company Filing History:

goldMedal19 out of 187 
 
Gruppo Lepetit S.p.a.
 patents

Years Active: 1976-1996

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5521155 - Amides of teicoplanin compounds (1996-05-28),
2. 5198418 - Substituted alkylamides of teicoplanin compounds (1993-03-30),
3. 5164484 - De-(acetylglucosaminyl-di(dehydro)-deoxy teicoplanin derivatives (1992-11-17),
4. 4789661 - De-(acetylglucosaminyl)-di(dehydro)-deoxy teicoplanin derivatives (1988-12-06),
5. 4788186 - 6-substituted-s-triazolo[3,4-a]phthalazine derivatives (1988-11-29),
6. 4783461 - 3,6-disubstituted triazolo [3,4-A]phthalazine derivatives (1988-11-08),
7. 4508730 - 1,7-Dihydro-pyrrolo[3,4-e][1,4]diazepin-2(3H)-one derivatives a process (1985-04-02),
8. 4402970 - 1,7-Dihydro-pyrrolo[3,4-e][1,4]diazepin-2(1H)-one derivatives (1983-09-06),
9. 4391817 - Pyrrolo-diazepine derivatives and their pharmaceutical compositions (1983-07-05),
10. 4212806 - Aminopyrrole derivatives (1980-07-15),
11. 4211709 - Aminopyrrole derivatives (1980-07-08),
12. 4211708 - Aminopyrrole derivatives (1980-07-08),
13. 4198502 - Aminopyrrole derivatives (1980-04-15),
14. 4140696 - Aminopyrrole derivatives (1979-02-20),
15. 4072689 - Monoamino 2,4,5-trisubstituted oxazoles (1978-02-07),

Title: Innovator Spotlight: Giorgio Tarzia

Introduction

Giorgio Tarzia is a prominent inventor based in Rome, Italy, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio that includes 19 patents, Tarzia's work primarily focuses on antibiotic compounds that target gram-positive bacteria.

Latest Patents

Among his latest innovations, Tarzia has developed two notable patents:

1. **Amides of Teicoplanin Compounds** - This invention pertains to an amide derivative of the glycopeptide teicoplanin, which exhibits antibiotic properties. The compound is synthesized through an amidation reaction involving teicoplanin, enhancing its efficacy against certain bacterial strains.

2. **Substituted Alkylamides of Teicoplanin Compounds** - This patent involves teicoplanin derivatives where position 63 of the glycopeptide core is modified with a substituted alkylamide. This alteration is designed to improve the antimicrobial activity of the compound.

Career Highlights

Tarzia has dedicated his career to advancing pharmaceutical innovations at Gruppo Lepetit S.p.A. His dedication to research and development has played a crucial role in the company’s commitment to improving healthcare solutions through effective antibiotic treatments.

Collaborations

Giorgio Tarzia collaborates closely with colleagues such as Gianbattista Panzone and Adriano Malabarba. These partnerships enhance the innovative processes within the laboratory, fostering an environment of creativity and scientific advancement.

Conclusion

Giorgio Tarzia stands as a leading figure in pharmaceutical innovation, with a focus on developing new antibiotic compounds through his patented inventions. His work not only contributes to the scientific community but also holds the potential for significant impacts in the treatment of bacterial infections, showcasing the importance of continuous innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…